Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

1.03
Delayed Data
As of Jun 24
 +0.0573 / +5.89%
Today’s Change
0.91
Today|||52-Week Range
7.60
-77.36%
Year-to-Date
No recent news for Fibrocell Science Inc.

Today’s Trading

Previous close0.97
Today’s open0.95
Day’s range0.91 - 1.06
Volume2,555,596
Average volume (3 months)203,127
Market cap$42.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-22.23%
Earnings growth (this year)+47.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+173.33%
P/E ratioNM
Price/Sales391.66
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
RNVARennova Health Inc-0.07-9.33%
RPBIFResponse Biomedical ...0.000.00%
CLDXCelldex Therapeutics...-0.21-4.60%
MGMistras Group Inc-1.32-5.21%
Data as of 4:03pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$492.0K
Annual profit (last year)-$34.5M
Net profit margin-7,002.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David M. Pernock
CFO, Treasurer &
Senior Vice President
Keith Alan Goldan
Corporate headquarters
Exton, Pennsylvania

Forecasts

Partner Offers

Search for Jobs